A Phase I Study of Gemtuzumab Ozogamicin (GO) in Combination with Busulfan and Cyclophosphamide (Bu/Cy) and Allogeneic Stem Cell Transplantation in Children with Poor-Risk CD33+ AML: A New Targeted Immunochemotherapy Myeloablative Conditioning (MAC) Regimen
Titel:
A Phase I Study of Gemtuzumab Ozogamicin (GO) in Combination with Busulfan and Cyclophosphamide (Bu/Cy) and Allogeneic Stem Cell Transplantation in Children with Poor-Risk CD33+ AML: A New Targeted Immunochemotherapy Myeloablative Conditioning (MAC) Regimen
Auteur:
Satwani, Prakash Bhatia, Monica Garvin Jr., James H. George, Diane Dela Cruz, Filemon Le Gall, John Jin, Zhezhen Schwartz, Joseph Duffy, Deirdre van de Ven, Carmella Foley, Sandra Hawks, Ria Morris, Erin Baxter-Lowe, Lee Ann Cairo, Mitchell S.
Verschenen in:
Biology of blood and marrow transplantation
Paginering:
Jaargang 18 (2012) nr. 2 pagina's 6 p.
Jaar:
2012
Inhoud:
Uitgever:
American Society for Blood and Marrow Transplantation